Axonics Modulation Technologies Insiders
Axonics Modulation employs about 797 people. The company is managed by 11 executives with a total tenure of roughly 44 years, averaging almost 4.0 years of service per executive, having 72.45 employees per reported executive. Break down of Axonics Modulation's management performance can provide insight into the company performance.
| Raymond Cohen CEO CEO, Director |
Axonics |
Axonics Modulation Management Team Effectiveness
Axonics Modulation's management efficiency ratios could be used to measure how well Axonics Modulation manages its routine affairs as well as how well it operates its assets and liabilities.Axonics Modulation Workforce Comparison
Axonics Modulation Technologies is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 139,385. Axonics Modulation maintains roughly 797 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.02) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.02. Axonics Modulation Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axonics Modulation insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axonics Modulation's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Axonics Modulation insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | ||
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | ||
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | ||
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | ||
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | ||
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | ||
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 | ||
Kari Keese over three months ago Disposition of 2083 shares by Kari Keese of Axonics Modulation subject to Rule 16b-3 |
Axonics Modulation Notable Stakeholders
An Axonics Modulation stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Axonics Modulation often face trade-offs trying to please all of them. Axonics Modulation's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Axonics Modulation's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Raymond Cohen | CEO, Director | Profile | |
| JD Esq | General VP | Profile | |
| Alfred Ford | Chief Commercial Officer | Profile | |
| Danny Dearen | Chief Operating and Financial Officer | Profile | |
| MD MAS | Chief Officer | Profile | |
| Rinda Sama | Chief Officer | Profile | |
| Aaron Pettit | General Officer | Profile | |
| Kari Keese | Chief Officer | Profile | |
| John Woock | Chief Marketing Officer | Profile | |
| Neil Bhalodkar | Vice Relations | Profile | |
| Guangqiang Jiang | Chief Officer | Profile |
Axonics Modulation Workforce Analysis
Traditionally, organizations such as Axonics Modulation use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Axonics Modulation within its industry.Axonics Modulation Manpower Efficiency
Return on Axonics Modulation Manpower
| Revenue Per Employee | 459.7K | |
| Revenue Per Executive | 33.3M | |
| Net Loss Per Employee | 7.6K | |
| Net Loss Per Executive | 553.5K | |
| Working Capital Per Employee | 559.1K | |
| Working Capital Per Executive | 40.5M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |